Jee Hyun Kim - Publications, H-index & Citations

Jee Hyun Kim

seoul national university

53H指数

491论文数

1.4W被引数

收录论文 140

发表时间

First-line durvalumab and tremelimumab in poor-prognosis unresectable hepatocellular carcinoma: Phase IIIb single-arm SIERRA study 一线度伐利尤单抗和特瑞普利单抗在预后不良的不可切除肝细胞癌中的应用：IIIb期单臂SIERRA研究

Journal of Hepatology

IF33

2026-10-06

PREAI

Stephen L. Chan; Masatoshi Kudo; Bruno Sangro; Robin Kate Kelley; Jee Hyun Kim; Binh Pham; Jung Yong Hong; Dirk-Thomas Waldschmidt; Donatella Marino; René Gerolami; Adam M. Burgoyne; Gianluca Masi; Robert John Walsh; Jens U. Marquardt; Ugochinyere Emeribe; Kavitha Balaji; Peng Sun; Boris Baur; Lorenza Rimassa

Heterogeneity of breast and nodal response to neoadjuvant pembrolizumab-based chemoimmunotherapy in early triple-negative breast cancer and its clinical significance 早期三阴性乳腺癌对基于帕博利珠单抗的新辅助化免疫治疗的乳腺和淋巴结反应异质性及其临床意义

Histopathology

IF4.1

2026-09-25

PREAI

Jiwon Koh; Koung Jin Suh; Hye Yeon Park; Hyun Jung Kwon; Hyun-Jung Sung; Han Suk Ryu; Jung Ho Kim; Jaemoon Koh; Kyung-Hun Lee; Dae-Won Lee; Changhee Park; Jeongmin Seo; Heejung Chae; Woochan Hwang; Ye Yoon Suh; Chang Ho Ahn; Seock-Ah Im; Jee Hyun Kim; So Yeon Park

Phase II study of trastuzumab-pkrb plus gedatolisib in patients with HER2-positive metastatic breast cancer who progressed after two or more HER2-directed therapies 曲妥珠单抗-pkrb联合吉地洛昔布在HER2阳性转移性乳腺癌患者中的II期研究，该患者在接受两种或更多HER2靶向治疗后进展

ESMO Open

IF8.3

2026-07-01

PREAI

Kim, J. W.; Park, V. H.; Lee, S.; Ahn, H. K.; Bae, J.; Park, S.; Chae, H.; Kim, J. H.; Lee, K. -h.; Kim, M. H.; Lee, K. E.; Kang, M. J.; Park, I. H.; Chae, V. s.; Lee, G. W.; Park, K. U.; Lee, E. M.; Park, J. H.; Kim, J. E.; Kim, H. K.; Kim, T. H.; Oh, S. V.; Ko, S.; Byun, J. H.; Ha, J. V.; Kwon, J. H.; Choi, J. V.; Jung, J. V.; Park, K. H.

Long-Term Response Without Immune-Related Adverse Events to Atezolizumab Treatment in TMB-High Thymoma: A Case Report from the KOSMOS-II Study

Journal of Clinical Medicine

IF2.9

2026-01-25

OAAI

In Hee Lee; Moonsik Kim; An Na Seo; Soo Jung Lee; Jee Hyun Kim

Association Between Genomic Features and Radiation Response in Metastatic Breast Cancer Patients Undergoing Palliative Radiotherapy 转移性乳腺癌患者接受姑息性放射治疗时，基因组特征与放射反应之间的关联

International Journal of Molecular Sciences 2025, Vol. 26, Page 11837

IF4.9

2025-12-08

OAAI

Hyeon Seok Choi; Sejoon Lee; So Yeon Park; Jee Hyun Kim; Se Hyun Kim; Koung Jin Suh; Seung Hyuck Jeon; In Ah Kim

Early Safety Results from the Phase 3b SIERRA Study of Durvalumab and Tremelimumab as First-Line Treatment for Participants with Unresectable Hepatocellular Carcinoma and a Poor Prognosis IIIb期SIERRA研究早期安全性结果：度伐利尤单抗和特瑞普利单抗作为不可切除肝细胞癌且预后不良患者的一线治疗方案。

Liver Cancer

IF9.1

2025-12-01

OAAI

Chan, Stephen Lam; Kudo, Masatoshi; Sangro, Bruno; Kelley, Robin Kate; Kim, Jee Hyun; Pham, Binh; Hong, Jung Yong; Waldschmidt, Dirk-Thomas; Marino, Donatella; Lee, Jie Xin Joycelyn; Gerolami, Rene; Burgoyne, Adam M.; Li, Qiao; Nakamura, Hitomi; Sun, Peng; Baur, Boris; Rimassa, Lorenza

Reversibility of immune checkpoint inhibitor-induced hypothyroidism

ENDOCRINE-RELATED CANCER

IF4.6

2025-11-01

PREAI

Seo, Jeongmin; Kim, Min Joo; Kang, Minsu; Jung, Eun Hee; Suh, Koung Jin; Kim, Ji-Won; Kim, Se Hyun; Kim, Jin Won; Kim, Yu Jung; Lee, Keun-Wook; Kim, Jee Hyun; Lee, Jong Seok; Cho, Sun Wook; Moon, Jae Hoon

Genomic and transcriptomic analyses of residual invasive triple-negative breast cancer after neoadjuvant chemotherapy in the prospective MIRINAE trial (a randomized phase II trial of adjuvant atezolizumab plus capecitabine compared to capecitabine; KCSG-BR18-21)MIRINAE试验（一项比较辅助阿替利珠单抗联合卡培他滨与单用卡培他滨的随机II期试验；KCSG-BR18-21）中，新辅助化疗后残留浸润性三阴性乳腺癌的基因组学和转录组学分析

ESMO Open

IF8.3

2025-09-24

PREAI

S.-A. Im; K. Park; J. Koh; C. Park; K.H. Jung; J. Lee; H.K. Ahn; A. Lee; S.H. Sim; M.H. Kim; J.H. Kim; J.H. Kim; K.E. Lee; K.H. Park; J. Bae; M.H. Lee; S. Lim; H.J. Kim; D.-W. Lee; J.H. Jeong; K.S. Lee; J. Sohn; K.J. Suh; J.-Y. Kim; Y.J. Cha; J. Moon; C.-Y. Ock; S.-B. Kim; K. Shin; H. Chae; G.M. Kim; K.-H. Lee; W.-Y. Park; Y.H. Park; I.H. Park

Hair cortisol as an indicator of chronic stress in Eurasian otters (Lutra lutra): Evaluating influencing variations 毛发皮质醇作为欧亚水獭（Lutra lutra）慢性应激指标的评估：评价影响因素

GENERAL AND COMPARATIVE ENDOCRINOLOGY

IF1.7

2025-09-01

PREAI

Kim, Jee Hyun; Kang, Hyejin; Kim, Bong Kyun; Min, Mi-Sook; Ma, Seung Aee; Cho, Je-Yoel

ALK-positive adult histiocytosis with a TFG-ALKfusion gene ALK阳性成人组织细胞增生症，伴有TFG-ALK融合基因

ONCOLOGIST

IF4.2

2025-09-01

OAAI

Lee, Ji Yun; Lee, Ki Rim; Na, Sei; Na, Hee Young; Lee, Sejoon; Kim, Sang-A; Lee, Jeong-Ok; Bang, Soo-Mee; Kim, Jee Hyun; Paik, Jin Ho

Relationship of Immediate Breast Reconstruction and the Development of Lymphedema in Breast Cancer Patients With Radiation Therapy 接受放射治疗的乳腺癌患者中，即刻乳房重建与淋巴水肿发生的关系。

International Journal of Radiation Oncology*Biology*Physics

IF0

2025-05-25

PREAI

Soon Woo Hong; Eun-Kyu Kim; Hee-Chul Shin; Jaewon Beom; Jae-Young Lim; Koung Jin Suh; Jee Hyun Kim; Chan Yeong Heo; Kyubo Kim; In Ah Kim

Common Inadequate Sleep Health Behaviors and Its Impact on Insomnia Symptoms in a Non-Clinical Population in Korea 韩国非临床人群中常见睡眠不足健康行为及其对失眠症状的影响

SLEEP

IF4.9

2025-05-19

PREAI

Kim, Jee Hyun; Yoon, Inho; Kim, Dongyeop; Lee, Hye Ah

Evaluating the Quality of ChatGPT's Responses to Adolescents' and Children's Sleep-Related Questions 评估ChatGPT对青少年和儿童睡眠相关问题的回答质量

SLEEP

IF4.9

2025-05-19

PREAI

Kim, Hannah; Park, Hea Ree; Song, Pamela; Cho, Jae Wook; Kim, Jee Hyun

Pairwise analysis of plasma cell-free DNA before and after palliative second-line paclitaxel plus ramucirumab treatment in patients with metastatic gastric cancer 转移性胃癌患者接受姑息性二线紫杉醇联合雷莫芦单抗治疗前后血浆游离DNA的配对分析

GASTRIC CANCER

IF5.1

2025-03-27

OAAI

Kim, Ji-Won; Kyung, Dong Soo; Ko, Won Yeong; Kim, Hwang-Phill; Hwang, Sung-Hyun; Kim, Kui-Jin; Lee, Ju Hyun; Seo, Jeongmin; Kang, Minsu; Jung, Eun Hee; Suh, Koung Jin; Kim, Se Hyun; Kim, Jin Won; Kim, Yu Jung; Kim, Jee Hyun; Lee, Keun-Wook

Impact of Estrogen Receptor Expression Levels on Chemo-responsiveness and Prognosis of Breast Cancer Patients Treated with Neoadjuvant Chemotherapy

LABORATORY INVESTIGATION

IF4.2

2025-03-01

PREAI

Bai, KyungAh; Kwon, Hyun Jung; Shin, Hee-Chul; Kim, Eun-Kyu; Kim, Jee; Kim, Se Hyun; Kim, Jee Hyun; Park, So Yeon

Updated efficacy and safety of SHR-A1811, an anti-HER2 antibody-drug conjugate, in heavily pretreated advanced solid tumors with HER2-expression or mutations: a global, multicenter, phase 1 study SHR-A1811，一种抗HER2抗体药物偶联物，在HER2表达或突变的重度预治晚期实体瘤中的更新疗效与安全性：一项全球、多中心、I期研究

BREAST

IF7.9

2025-02-01

OAAI

Yao, H.; Yan, M.; Tong, Z.; Wu, X.; Yin, Y.; Ryu, M. -h.; Park, J. J.; Dai, T.; Zhao, Y.; Kim, J. H.; Wang, S.; Zhong, Y.; Voskoboynik, M.; Zhang, J.; Kaubisch, A.; Liu, C.; Chen, Y.; Im, S. -a.; Wu, L.; Liu, Y.; Ganju, V.; Barve, M.; Li, H.; Yao, G.; Bao, L.; Teng, Y.; Qian, J.; Zhou, H.; Zhao, J.; Zhao, K.; Shen, Y.; Rong, S.; Zhu, X.; Song, E.

Association of TP53 Mutation Status and Sex with Clinical Outcome in Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Retrospective Cohort Study TP53突变状态与性别对接受免疫检查点抑制剂治疗的非小细胞肺癌患者临床结局的影响：一项回顾性队列研究

CANCER RESEARCH AND TREATMENT

IF3.8

2025-01-15

OAAI

Choi, Songji; Kim, Se Hyun; Lee, Sejoon; Seo, Jeongmin; Kang, Minsu; Jung, Eun Hee; Kim, Sang-A; Suh, Koung Jin; Lee, Ji Yun; Kim, Ji-Won; Kim, Jin Won; Lee, Jeong-Ok; Kim, Yu Jung; Lee, Keun-Wook; Kim, Jee Hyun; Bang, Soo-Mee; Lee, Jong Seok

Characterization of tumor-infiltrating lymphocytes and their spatial distribution in triple-negative breast cancer 三阴性乳腺癌中肿瘤浸润淋巴细胞的特征及其空间分布

BREAST CANCER RESEARCH

IF5.6

2024-12-06

OAAI

Han, Eunkyung; Choi, Hye Yeon; Kwon, Hyun Jung; Chung, Yul Ri; Shin, Hee-Chul; Kim, Eun-Kyu; Suh, Koung Jin; Kim, Se Hyun; Kim, Jee Hyun; Park, So Yeon

Alteration of HER2 Status During Breast Cancer Progression: A Clinicopathological Analysis Focusing on HER2-Low Status 乳腺癌进展过程中HER2状态的改变: 以HER2-Low状态为重点的临床病理分析

LABORATORY INVESTIGATION

IF4.2

2024-08-01

PREAI

Bai, Kyungah; Woo, Ji Won; Kwon, Hyun Jung; Chung, Yul Ri; Suh, Koung Jin; Kim, Se Hyun; Kim, Jee Hyun; Park, So Yeon

Inhibition of lysine acetyltransferase KAT6 in ER+HER2- metastatic breast cancer: a phase 1 trial (jun, 10.1038/s41591-024-03060-0, 2024)

NATURE MEDICINE

IF50

2024-06-24

OAAI

Mukohara, Toru; Park, Yeon Hee; Sommerhalder, David; Yonemori, Kan; Hamilton, Erika; Kim, Sung-Bae; Kim, Jee Hyun; Iwata, Hiroji; Yamashita, Toshinari; Layman, Rachel M.; Mita, Monica; Clay, Timothy; Chae, Yee Soo; Oakman, Catherine; Yan, Fengting; Kim, Gun Min; Im, Seock-Ah; Lindeman, Geoffrey J.; Rugo, Hope S.; Liyanage, Marlon; Saul, Michelle; Le Corre, Christophe; Skoura, Athanasia; Liu, Li; Li, Meng; LoRusso, Patricia M.

研究方向